Insider Trading Alert - HRL, OPK, ATU, IBKR And HXL Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Friday, Jan. 10, 2014, 51 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $600.00 to $8,688,240.00.

Highlighted Stocks Traded by Insiders:

Hormel Foods Corporation (HRL) - FREE Research Report

Pippins Dakota A who is Director at Hormel Foods Corporation sold 1,725 shares at $44.92 on Jan. 10, 2014. Following this transaction, the Director owned 44,106 shares meaning that the stake was reduced by 3.76% with the 1,725-share transaction.

The shares most recently traded at $45.33, up $0.41, or 0.92% since the insider transaction. Historical insider transactions for Hormel Foods Corporation go as follows:

  • 4-Week # shares sold: 2,400
  • 12-Week # shares sold: 2,400
  • 24-Week # shares sold: 2,400

The average volume for Hormel Foods Corporation has been 684,300 shares per day over the past 30 days. Hormel Foods Corporation has a market cap of $11.9 billion and is part of the consumer goods sector and food & beverage industry. Shares are up 0.91% year-to-date as of the close of trading on Friday.

Hormel Foods Corporation produces and markets various meat and food products in the United States and internationally. The company operates in five segments: Grocery Products, Refrigerated Foods, Jennie-O Turkey Store, Specialty Foods, and International & Other. The stock currently has a dividend yield of 1.77%. The company has a P/E ratio of 23.1. Currently there are 4 analysts that rate Hormel Foods Corporation a buy, 2 analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on HRL - FREE

TheStreet Quant Ratings rates Hormel Foods Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, increase in net income and solid stock price performance. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Hormel Foods Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Opko Health (OPK) - FREE Research Report

Frost Phillip Md Et Al who is CEO & Chairman at Opko Health bought 9,500 shares at $8.46 on Jan. 10, 2014. Following this transaction, the CEO & Chairman owned 137.8 million shares meaning that the stake was reduced by 0.01% with the 9,500-share transaction.

Baron Robert A who is Director at Opko Health sold 46,730 shares at $8.48 on Jan. 10, 2014. Following this transaction, the Director owned 285,965 shares meaning that the stake was reduced by 14.05% with the 46,730-share transaction.

The shares most recently traded at $9.01, up $0.53, or 5.85% since the insider transaction. Historical insider transactions for Opko Health go as follows:

  • 4-Week # shares bought: 10,000
  • 12-Week # shares bought: 10,000
  • 24-Week # shares bought: 10,000

The average volume for Opko Health has been 5.1 million shares per day over the past 30 days. Opko Health has a market cap of $3.4 billion and is part of the health care sector and health services industry. Shares are up 2.25% year-to-date as of the close of trading on Friday.

Opko Health, Inc., a pharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies. It operates in two segments, Pharmaceuticals and Diagnostics. Currently there are 3 analysts that rate Opko Health a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OPK - FREE

TheStreet Quant Ratings rates Opko Health as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and weak operating cash flow. Get the full Opko Health Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Actuant (ATU) - FREE Research Report

Sefcik Mark who is Exec VP Industrial Segment at Actuant bought 7,000 shares at $35.93 on Jan. 10, 2014. Following this transaction, the Exec VP Industrial Segment owned 40,532 shares meaning that the stake was reduced by 20.88% with the 7,000-share transaction.

The shares most recently traded at $36.13, up $0.20, or 0.55% since the insider transaction. Historical insider transactions for Actuant go as follows:

  • 4-Week # shares sold: 110,000
  • 12-Week # shares sold: 131,731
  • 24-Week # shares sold: 149,603

The average volume for Actuant has been 502,500 shares per day over the past 30 days. Actuant has a market cap of $2.6 billion and is part of the industrial goods sector and industrial industry. Shares are down 1.61% year-to-date as of the close of trading on Friday.

Actuant Corporation designs, manufactures, and distributes a range of industrial products and systems worldwide. It operates in three segments: Industrial, Energy, and Engineered Solutions. The stock currently has a dividend yield of 0.11%. Currently there are 4 analysts that rate Actuant a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ATU - FREE

TheStreet Quant Ratings rates Actuant as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, growth in earnings per share and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Actuant Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Interactive Brokers Group (IBKR) - FREE Research Report

Galik Milan who is SVP Software Development at Interactive Brokers Group sold 2,000 shares at $23.73 on Jan. 10, 2014. Following this transaction, the SVP Software Development owned 839,517 shares meaning that the stake was reduced by 0.24% with the 2,000-share transaction.

The shares most recently traded at $22.88, down $0.85, or 3.69% since the insider transaction. Historical insider transactions for Interactive Brokers Group go as follows:

  • 4-Week # shares sold: 15,000
  • 12-Week # shares sold: 51,000
  • 24-Week # shares sold: 110,000

The average volume for Interactive Brokers Group has been 570,500 shares per day over the past 30 days. Interactive Brokers Group has a market cap of $1.1 billion and is part of the financial sector and financial services industry. Shares are down 6.08% year-to-date as of the close of trading on Friday.

Interactive Brokers Group, Inc. operates as an automated electronic broker and market maker. The stock currently has a dividend yield of 1.75%. The company has a P/E ratio of 26.6. Currently there are 2 analysts that rate Interactive Brokers Group a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on IBKR - FREE

TheStreet Quant Ratings rates Interactive Brokers Group as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income, revenue growth, reasonable valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Interactive Brokers Group Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Hexcel Corporation (HXL) - FREE Research Report

Brubaker Lynn who is Director at Hexcel Corporation sold 3,143 shares at $45.13 on Jan. 10, 2014. Following this transaction, the Director owned 3,500 shares meaning that the stake was reduced by 47.31% with the 3,143-share transaction.

The shares most recently traded at $45.47, up $0.34, or 0.74% since the insider transaction. Historical insider transactions for Hexcel Corporation go as follows:

  • 4-Week # shares sold: 2,790
  • 12-Week # shares sold: 2,790
  • 24-Week # shares sold: 17,790

The average volume for Hexcel Corporation has been 510,800 shares per day over the past 30 days. Hexcel Corporation has a market cap of $4.5 billion and is part of the industrial goods sector and aerospace/defense industry. Shares are up 1.36% year-to-date as of the close of trading on Friday.

Hexcel Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of lightweight and high-performance structural materials for use in commercial aerospace, space and defense, and industrial applications. The company has a P/E ratio of 25.8. Currently there are 7 analysts that rate Hexcel Corporation a buy, 1 analyst rates it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HXL - FREE

TheStreet Quant Ratings rates Hexcel Corporation as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Hexcel Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

U.S. Banks Pass Fed 'Stress Test' With Room for Dividends, Buybacks

U.S. Banks Pass Fed 'Stress Test' With Room for Dividends, Buybacks

Comcast's Brian Roberts vs. Disney's Bob Iger: Which Titan Will Nab Fox?

Comcast's Brian Roberts vs. Disney's Bob Iger: Which Titan Will Nab Fox?

Online Retailers Hit by Supreme Court Ruling Requiring Sales Tax Collection

Online Retailers Hit by Supreme Court Ruling Requiring Sales Tax Collection

Dow Logs Eighth Straight Drop as Stocks Slump

Dow Logs Eighth Straight Drop as Stocks Slump

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech